Acura Pharmaceuticals, Inc. Stock Nasdaq
Equities
US00509L7038
Biotechnology & Medical Research
Financials (USD)
Sales 2020 | 3.57M | Sales 2021 | 1.56M | Capitalization | 32.54M |
---|---|---|---|---|---|
Net income 2020 | -1M | Net income 2021 | - | EV / Sales 2020 | 2.91 x |
Net Debt 2020 | 5.86M | Net Debt 2021 | 135K | EV / Sales 2021 | 20.9 x |
P/E ratio 2020 |
-5.25
x | P/E ratio 2021 |
-25
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 15.27% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Jones
CEO | Chief Executive Officer | 65 | 08-04-06 |
Peter Clemens
DFI | Director of Finance/CFO | 71 | 98-01-31 |
Bob Seiser
AUD | Comptroller/Controller/Auditor | 60 | 98-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Clemens
DFI | Director of Finance/CFO | 71 | 98-01-31 |
Bruce Wesson
BRD | Director/Board Member | 81 | 98-02-28 |
William Skelly
BRD | Director/Board Member | 73 | 96-04-30 |
1st Jan change | Capi. | |
---|---|---|
-2.28% | 103B | |
+0.60% | 95.71B | |
+1.69% | 22.02B | |
-16.84% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.55% | 15.52B | |
+3.28% | 13.86B | |
+34.56% | 12.04B |